Nachbericht

23. Consensus Meeting der AG Herzinsuffizienz

Am 27. Jänner 2024 fand das 23. Consensus Meeting der Arbeitsgruppe Herzinsuffizienz der Österreichischen Kardiologischen Gesellschaft (ÖKG) in Wien statt. Fünf Fachvorträge behandelten das Thema Atemnot bei Herzinsuffizienz, moderiert von Univ.-Doz. Dr. Martin Hülsmann, AKH Wien, und Priv.-Doz. Dr. Deddo Mörtl, Universitätsklinikum St. Pölten.

Inhaltsverzeichnis

Lebensqualität
Notfallmedizin
Lungenhochdruck
Herzinsuffizienz
Klappenerkrankungen

Lebensqualität

Noch kein Benutzerkonto?

Jetzt kostenlos registrieren!

Ihre Vorteile:

Exklusive Fachbeiträge
DFP-Fortbildungen, jederzeit und von überall
Kongresskalender, alle Events auf einen Blick
Daily Doc Newsletter, täglich die wichtigsten News aus der Branche

Jetzt registrieren

Artikel Info

Autor:in:

Dr. Noel G. Panagiotides

Erstellt am:

12. März 2024

Stand der medizinischen Information:

27. Januar 2024

ICD-Code:

Quellen:

23. Consensus Meeting der AG Herzinsuffizienz

Literatur

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368.
Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23(23):1867-1876. doi:10.1053/EUHJ.2002.32552.
Turgeon RD, Barry AR, Hawkins NM, Ellis UM. Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis. Eur J Heart Fail. 2021;23(4):578-589. doi:10.1002/EJHF.2141.
Reddy P, Dias I, Holland C, et al. Walking football as sustainable exercise for older adults - A pilot investigation. Eur J Sport Sci. 2017;17(5):638-645. doi:10.1080/17461391.2017.1298671.
Berliner D, Schneider N, Welte T, Bauersachs J. The differential diagnosis of dyspnoea. Dtsch Arztebl Int. 2016;113(49):834-844. doi:10.3238/arztebl.2016.0834.
Perkins GD, Gräsner J-T, Semeraro F, et al. European Resuscitation Council Guidelines 2021: Executive summary. Published online 2021. doi:10.1016/j.resuscitation.2021.02.003.
Michalke JA. An overview of emergency ultrasound in the United States. World J Emerg Med. 2012;3(2):85. doi:10.5847/WJEM.J.ISSN.1920-8642.2012.02.001.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. doi:10.1093/eurheartj/ehaa575.
Konstantinides S V., Meyer G, Bueno H, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.
Farber HW, Miller DP, Poms AD, et al. Five-Year outcomes of patients enrolled in the REVEAL Registry. Chest. 2015;148(4):1043-1054. doi:10.1378/CHEST.15-0300.
Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension Developed by the Task Force for the Diagnosis and Treatment of (ESC) and the European Respiratory Society (ERS). Eur Heart J. 2022;00:1-114.
Pugliese NR, Mazzola M, Madonna R, et al. Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment. Vascul Pharmacol. 2022;144:106978. doi:10.1016/J.VPH.2022.106978.
Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348(20):2007-2018. doi:10.1056/NEJMra021498.
Morciano G, Vitto VAM, Bouhamida E, Giorgi C, Pinton P. Mitochondrial Bioenergetics and Dynamism in the Failing Heart. Life 2021, Vol 11, Page 436. 2021;11(5):436. doi:10.3390/LIFE11050436.
Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Hear Fail. 2017;4(4):492-498. doi:10.1002/EHF2.12237.
Hülsmann M, Quittan M, Berger R, et al. Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur J Heart Fail. 2004;6(1):101-107. doi:10.1016/J.EJHEART.2003.07.008.
Waagstein F. Beta-Blockers in Congestive Heart Failure: the Evolution of a New Treatment Concept-Mechanisms of Action and Clinical Implications. J Clin Basic Cardiol. 2002;5(3):215-223. Accessed February 7, 2024. www.kup.at/jcbc.
Liang B, Zhao YX, Zhang XX, Liao HL, Gu N. Reappraisal on pharmacological and mechanical treatments of heart failure. Cardiovasc Diabetol. 2020;19(1):1-19. doi:10.1186/s12933-020-01024-5.
Docherty KF, Vaduganathan M, Solomon SD, McMurray JJV. Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF. JACC Heart Fail. 2020;8(10):800-810. doi:10.1016/J.JCHF.2020.06.020.
McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37). doi:10.1093/EURHEARTJ/EHAD195
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed). 2022;75(6):524. doi:10.1016/j.rec.2022.05.006.
Carabello BA, Paulus WJ. Aortic stenosis. Lancet (London, England). 2009;373(9667):956-966. doi:10.1016/S0140-6736(09)60211-7.
Strange G, Stewart S, Celermajer D, et al. Poor Long-Term Survival in Patients With Moderate Aortic Stenosis. J Am Coll Cardiol. 2019;74(15):1851-1863. doi:10.1016/J.JACC.2019.08.004.

Lebensqualität

Jetzt kostenlos registrieren!

Loggen Sie sich hier ein

Einloggen